health news today obesity drugs glp-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Exercise Remains Crucial Alongside GLP-1
Description
Available at: Key Patent Information Eng J
As such, postprandial secretion of GIP, GLP-1, and GLP-2 inhibits bone resorption and/or promotes bone formation, representing a gut-bone axis
Sun B, Willard FS, Feng D, Alsina-Fernandez J, Chen Q, Vieth M, Ho JD, Showalter AD, Stutsman C, Ding L, et al
2020 Mar;8(3):e2
Almutairi M, Gopal K, Greenwell AA, Young A, Gill R, Aburasayn H, Al Batran R, Chahade JJ, Gandhi M, Eaton F
